Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 11,826 shares at $39.60 ($477K) on 2022-01-06, disclosed to the SEC on 2022-01-10.
Open-market sale of $477k HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.60 | 1,399 | $55K | 11.6% |
| 2 | $39.60 | 1,399 | $55K | 11.6% |
| 3 | $40.53 | 4,302 | $174K | 36.6% |
| 4 | $40.53 | 4,302 | $174K | 36.6% |
| 5 | $41.23 | 424 | $17K | 3.7% |
| Total | $40.34 avg | 11,826 |
| $477K |
| 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |